Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 288 entries
View as:

CKD-828(80/2.5mg) Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT01246193 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

Study to Evaluate the Safety and Pharmacokinetics of CKD-379

Phase: N/A Priority: Normal
NCT ID: NCT05952219 Org: User:
Start: 06/02/23 End: 10/30/23 Due: 10/30/24

A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT05677438 Org: User:
Start: 12/20/22 End: 12/15/23 Due: 12/15/24

Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03868072 Org: User:
Start: 02/22/19 End: 04/20/19 Due: 04/20/20

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Phase: N/A Priority: Normal
NCT ID: NCT05928637 Org: User:
Start: 07/10/23 End: 09/05/23 Due: 09/05/24

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

Phase: N/A Priority: Normal
NCT ID: NCT03616392 Org: User:
Start: 07/25/18 End: 11/13/18 Due: 11/13/19

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04611932 Org: User:
Start: 11/11/20 End: 04/27/21 Due: 04/27/22

Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Phase: N/A Priority: Normal
NCT ID: NCT01630018 Org: User:
Start: 01/31/11 End: 06/30/14 Due: 06/30/15

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Phase: N/A Priority: Normal
NCT ID: NCT05452525 Org: User:
Start: 07/26/22 End: 09/21/22 Due: 09/21/23

Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

Phase: N/A Priority: Normal
NCT ID: NCT03794492 Org: User:
Start: 03/31/18 End: 04/27/23 Due: 04/27/24

Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01685671 Org: User:
Start: 10/26/12 End: 01/15/13 Due: 01/15/14

Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01746680 Org: User:
Start: 08/31/12 End: 06/30/15 Due: 06/30/16

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03609606 Org: User:
Start: 08/09/18 End: 09/27/18 Due: 09/27/19

CKD-330 Drug-Drug Interaction Study (Amlodipine)

Phase: N/A Priority: Normal
NCT ID: NCT02064556 Org: User:
Start: 05/31/14 End: 07/31/14 Due: 07/31/15

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT05657574 Org: User:
Start: 11/24/22 End: 06/30/23 Due: 06/30/24

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

Phase: N/A Priority: Normal
NCT ID: NCT03382756 Org: User:
Start: 10/12/17 End: 11/07/17 Due: 11/07/18

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Phase: N/A Priority: Normal
NCT ID: NCT02827890 Org: User:
Start: 04/30/16 End: 05/31/16 Due: 05/31/17

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT04204603 Org: User:
Start: 11/30/18 End: 10/29/19 Due: 10/29/20

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03726866 Org: User:
Start: 08/31/18 End: 01/15/19 Due: 01/15/20

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02651870 Org: User:
Start: 04/22/15 End: 02/29/16 Due: 02/28/17

Efficacy and Safety of Lobeglitazone Versus Sitagliptin

Phase: N/A Priority: Normal
NCT ID: NCT02480465 Org: User:
Start: 01/31/15 End: 03/31/17 Due: 03/31/18

Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06942156 Org: User:
Start: 08/14/25 End: 12/31/30 Due: 12/31/31

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06121518 Org: User:
Start: 07/31/23 End: 03/26/24 Due: 03/26/25

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Phase: N/A Priority: Normal
NCT ID: NCT05816759 Org: User:
Start: 05/26/23 End: 06/22/23 Due: 06/22/24

Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT04511000 Org: User:
Start: 10/11/17 End: 05/20/19 Due: 05/20/20